Akèy › Kadiyomiopati Ipertrofik › Missouri
Etid klinik pou Kadiyomiopati Ipertrofik nan Missouri
3 etid pou Kadiyomiopati Ipertrofik ap chèche patisipan nan sit nan Missouri.
Tèks ofisyèl etid la (Anglè)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's Mid-America Heart Institute, Kansas City
- Washington University, St Louis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
- St. Luke's Hospital - Mid America Heart Institute, Kansas City
Ap rekriteFaz 4
Laj 18 a 90 · Tout sèks · Mizajou May 20, 2026 · NCT07600177A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT07023614Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.